Campagnolo D - Search Results

1

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay.

Campagnolo D, Dong Q, Lee L, Ho PR, Amarante D, Koendgen H. Campagnolo D, et al. J Neurovirol. 2016 Dec;22(6):880-881. doi: 10.1007/s13365-016-0482-z. Epub 2016 Oct 11. J Neurovirol. 2016. PMID: 27730447 Free PMC article. No abstract available.

2

Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.

Perumal J, Balabanov R, Su R, Chang R, Balcer L, Galetta S, Campagnolo DI, Avila R, Lee L, Rutledge D, Fox RJ. Perumal J, et al. Among authors: campagnolo di. Adv Ther. 2021 Jul;38(7):3724-3742. doi: 10.1007/s12325-021-01722-w. Epub 2021 May 20. Adv Ther. 2021. PMID: 34014549 Free PMC article.

3

Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.

Perumal J, Balabanov R, Su R, Chang R, Balcer L, Galetta S, Campagnolo DI, Avila R, Lee L, Rutledge D, Fox RJ. Perumal J, et al. Among authors: campagnolo di. Adv Ther. 2021 Jul;38(7):3743-3744. doi: 10.1007/s12325-021-01815-6. Adv Ther. 2021. PMID: 34159559 Free PMC article. No abstract available.

4

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B. Plavina T, et al. Among authors: campagnolo d. Ann Neurol. 2014 Dec;76(6):802-12. doi: 10.1002/ana.24286. Epub 2014 Oct 24. Ann Neurol. 2014. PMID: 25273271 Free PMC article.

5

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators. Lublin FD, et al. Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11. Ann Neurol. 2013. PMID: 23424159 Free PMC article. Clinical Trial.

6

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.

Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group. Govindarajan KA, et al. Hum Brain Mapp. 2015 Oct;36(10):3749-3760. doi: 10.1002/hbm.22875. Epub 2015 Jun 19. Hum Brain Mapp. 2015. PMID: 26096844 Free PMC article. Clinical Trial.

7

Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.

Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G, Campagnolo D. Fox RJ, et al. Among authors: campagnolo d. Int J MS Care. 2013 Winter;15(4):194-201. doi: 10.7224/1537-2073.2012-034. Int J MS Care. 2013. PMID: 24453783 Free PMC article.

8

Disability Progression After Switching from Natalizumab to Fingolimod or Interferon Beta/Glatiramer Acetate Therapies: A NARCOMS Analysis.

Cofield SS, Fox RJ, Tyry T, Salter AR, Campagnolo D. Cofield SS, et al. Among authors: campagnolo d. Int J MS Care. 2016 Sep-Oct;18(5):230-238. doi: 10.7224/1537-2073.2014-113. Int J MS Care. 2016. PMID: 27803638 Free PMC article.

9

Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.

Kaufman M, Cree BA, De Sèze J, Fox RJ, Gold R, Hartung HP, Jeffery D, Kappos L, Montalbán X, Weinstock-Guttman B, Ticho B, Duda P, Pace A, Campagnolo D. Kaufman M, et al. Among authors: campagnolo d. J Neurol. 2015 Feb;262(2):326-36. doi: 10.1007/s00415-014-7558-6. Epub 2014 Nov 9. J Neurol. 2015. PMID: 25381458 Clinical Trial.

10

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.

Hersh CM, Kieseier B, de Moor C, Miller DM, Campagnolo D, Williams JR, Fitzgerald KC, Xiong K, McGinley MP, Hyland M, Rudick RA, Ziemssen T, Koulinska I. Hersh CM, et al. Among authors: campagnolo d. Mult Scler J Exp Transl Clin. 2021 Apr 15;7(2):20552173211004634. doi: 10.1177/20552173211004634. eCollection 2021 Apr-Jun. Mult Scler J Exp Transl Clin. 2021. PMID: 33948221 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters